๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses

โœ Scribed by Rodney C. P. Go; Rodney T. Perry; Howard Wiener; Susan S. Bassett; Deborah Blacker; Bernie Devlin; Robert A. Sweet

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
93 KB
Volume
139B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Association of serum AACT levels and AAC
Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland
โœ S. P. McIlroy; M. D. Vahidassr; D. A. Savage; F. Lloyd; C. C. Patterson; J. T. L ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB ๐Ÿ‘ 1 views

a1-antichymotrypsin (AACT) is a serine protease inhibitor that has been associated with amyloid plaques in the brains of patients with Alzheimer's disease (AD). It has been reported that AACT serum levels are higher in AD patients than in age and sex matched controls. In addition, polymorphisms in t

No association or linkage between an int
No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease
โœ W.K. Scott; L.H. Yamaoka; P.A. Locke; B.L. Rosi; P.C. Gaskell; A.M. Saunders; P. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 1 views

Recent reports have shown an association between an intronic polymorphism of the presenilin-1 (PSEN1) gene and late-onset (age at onset > 65) familial and sporadic (no family history) Alzheimer disease (AD). The reported association was independent of the effect of the only previously identified gen